60 Results for "

p97

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "p97" in MCE Product Catalog:

  • Targets Recommended:
53
53 Publications Verification
Cat. No.: HY-12861
CAS No.: 1542705-92-9
Purity:  99.90%
Target:  

p97

Research Areas:  

Cancer

CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP. CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-15713
CAS No.: 1418013-75-8
Purity:  99.92%
Target:  

p97

Research Areas:  

Cancer

NMS-873 is a potent, selective allosteric VCP/p97 inhibitor with an IC50 value of 30 nM.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-110078
CAS No.: 412960-54-4
Purity:  99.56%
Target:  

p97 Apoptosis

Research Areas:  

Cancer

Eeyarestatin I, a potent endoplasmic reticulum-associated protein degradation (ERAD) inhibitor, is a potent protein translocation inhibitor. Eeyarestatin I inhibits Sec61 translocon. Eeyarestatin I targets the p97-associated deubiquitinating process (PAD) and inhibits atx3-dependent deubiquitination. Eeyarestatin I interferes at a step prior to proteasomal degradation. Eeyarestatin I induces cell death via the proapoptotic protein NOXA and has anticancer effects .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15945
CAS No.: 177355-84-9
Synonyms: JRF 12
Target:  

p97 Autophagy Apoptosis

Research Areas:  

Cancer

DBeQ is a selective, potent, reversible, and ATP-competitive p97 inhibitor, with an IC50 value of 1.5 μM and 1.6 μM for p97(wt) and p97(C522A), respectively; DBeQ also inhibits Vps4 with an IC50 of 11.5 μM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19795
CAS No.: 1346527-98-7
Target:  

p97

Research Areas:  

Cancer

ML240 is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-128724
CAS No.: 1863952-15-1
Purity:  99.58%
Target:  

p97

Research Areas:  

Cancer

CB-5339 is an oral activity potent p97 inhibitor with an IC50 <30 nM. CB-5339 can be used for leukemia research . CB-5339 extracted from WO2015109285A1 compound FF07.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123872
CAS No.: 2219320-08-6
Purity:  99.89%
Target:  

p97

Research Areas:  

Cancer

MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively . MSC1094308 inhibits the D2 ATPase activity by binding to a agentable hotspot of p97. MSC1094308 can be used in study of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-11067
CAS No.: 211555-05-4
Purity:  99.70%
Target:  

JAK

Research Areas:  

Inflammation/Immunology

WHI-P97 is a potent and selective JAK-3 inhibitor. WHI-P97 is effective in preventing the development allergic asthma in vivo .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15714
CAS No.: 1449236-96-7
Purity:  98.05%
Target:  

p97

Research Areas:  

Cancer

NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W111581
CAS No.: 13681-87-3
Synonyms: Diethyldithiocarbamic acid copper salt
Target:  

Apoptosis Caspase

Research Areas:  

Cancer

Copper(II) diethyldithiocarbamate (Diethyldithiocarbamic acid copper salt) is a Copper(II) and diethyldithiocarbamate coordination polymer. Copper(II) diethyldithiocarbamate binds tightly to NPL4 and induces its aggregation, disrupting the p97-NPL4-UFD1 pathway. Copper(II) diethyldithiocarbamate causes ubiquitinated proteins accumulation and impairs waste proteins degradation, thus resulting in cell apoptosis. Copper(II) diethyldithiocarbamate inhibits tumor growth in MDA-MB-231 xenograft mice models. Copper(II) diethyldithiocarbamate can be used for the research of cancer, such as breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139606
CAS No.: 2630950-38-6
Target:  

p97

Research Areas:  

Cancer

VCP/p97 inhibitor-1 is a potent inhibitor of VCP/p97 (also called Cdc48, CDC-. 48, or Ter94) with an IC50 of 54.7 nM. VCP/p97 inhibitor-1 causes the dysregulation of protein homeostasis and disturbs the degradation of misfolded polypeptides by the ubiquitin-proteasome system (UPS) .
loading...
    loading...
Cat. No.: HY-123636
CAS No.: 1883351-01-6
Purity:  ≥99.0%
Target:  

p97

Research Areas:  

Cancer

UPCDC-30245 is an allosteric p97 inhibitor with an IC50 of approximately 27 nM . UPCDC-30245 inhibits the p97 mutant N660K similar to wild type (WT; IC50=300 nM) and shows 3-fold resistance for p97 mutant T688A . UPCDC-30245 can be used in the research of cancer .
loading...
    loading...
Cat. No.: HY-19797A
CAS No.: 2070015-13-1
Target:  

p97

Research Areas:  

Cancer

ML241 hydrochloride is a potent p97 inhibitor, inhibiting p97 ATPase with IC50 value of 100 nM.
loading...
    loading...
Cat. No.: HY-137342
CAS No.: 2769753-18-4
Purity:  98.70%
SB1-G-187 is a multi-target kinase PROTAC degrader with activity against various kinases including GCK, YES1, IRAK1 and LYN. SB1-G-187 induces degradation of target kinases via a p97-dependent pathway, and forms ternary complexes with CRBN and specific functional kinases. SB1-G-187 can be used in tumor-related research .
loading...
    loading...
Cat. No.: HY-138233
CAS No.: 1357164-52-3
Purity:  99.76%
Target:  

p97

KUS121, a valosin-containing protein (VCP, p97) modulator with significant neuroprotective effects, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress .
loading...
    loading...
Cat. No.: HY-19797
CAS No.: 1346528-06-0
Target:  

p97

Research Areas:  

Cancer

ML241 is a potent, selective and competitive p97 ATPase inhibitor with an IC50 of 0.11 μM. ML241 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-148122
CAS No.: 2749599-78-6
Target:  

p97

Research Areas:  

Cancer

NW 1028 is a potent VCP/p97 inhibitor. NW 1028 targets the ND1L domain of p97 and inhibits the degradation of a p97-dependent reporter. NW 1028 has good binding affinity with Kd values of 100 and 285 nM for ND1L and full length p97, respectively. NW 1028 has the function of regulating the mitotic spindle of cells .
loading...
    loading...
Cat. No.: HY-124776
CAS No.: 696655-62-6
Purity:  99.92%
Target:  

p97

Research Areas:  

Cancer

NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration. NPD8733 specifically binds to valosin-containing protein (VCP)/p97, a member of the ATPase-associated with diverse cellular activities (AAA+) protein family. NPD8733 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-174984
CAS No.: 3098437-66-9
Target:  

p97 Caspase p62

Research Areas:  

Cancer

VCP/p97 IN-3 is a VCP/p97 allosteric inhibitor. VCP/p97 IN-3 shows the inhibitory activity against the VCP proteins with an IC50 of 9 nM and the mutant VCP proteins with IC50 of 12 nM (N660K) and 19 nM (V474A/D649A). VCP/p97 IN-3 increases K48-linked ubiquitination and the level of cleaved caspase-3. VCP/p97 IN-3 activates ER-stress and the UPR. VCP/p97 IN-3 inhibits tumor growth in RPMI-8226 cell subcutaneous xenograft mouse models. VCP/p97 IN-3 can be used for the study of multiple myeloma .
loading...
    loading...
Cat. No.: HY-RS15621
Research Areas:  

Others

VCP Human Pre-designed siRNA Set A contains three designed siRNAs for VCP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...